Pipeline Trends December 2016

Thursday, December 8, 2016
Cover of December Pipeline Trends
Timothy Cummins, MBA, BS, RPh
Commonwealth Medicine

Pipeline Trends is produced by UMass Medical School’s Clinical Pharmacy Services division and is distributed at least once a year. This edition provides a comprehensive overview of:

  • Promising New Agents: Abaloparatide, Cannabidiol, Dupilumab, and others
  • Projected Generic Entry: Strattera®, Tamiflu®, Truvada®, Zetia®, and others
  • Investigational Indications: Cabozantinib and Tofacitinib
  • FDA Updates
  • Industry Trends